Works by Liu, Maobai

Results: 66

Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 7, p. 965, doi. 10.1007/s00228-024-03665-x

By:

Cheng, Yu;
Zhang, Yujia;
Zhang, Ying;
Liu, Maobai;
Zhao, Limei

Publication type:

Article

External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 9, p. 1447, doi. 10.1007/s00228-022-03359-2

By:

Huang, Weikun;
Zheng, You;
Huang, Huiping;
Cheng, Yu;
Liu, Maobai;
Chaphekar, Nupur;
Wu, Xuemei

Publication type:

Article

High Serum Estradiol Reduces Acute Hepatotoxicity Risk Induced by Epirubicin Plus Cyclophosphamide Chemotherapy in Premenopausal Women with Breast Cancer.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.572444

By:

Huang, Shunmin;
Liu, Maobai;
Fu, Fangmeng;
Liu, Hangmin;
He, Baochang;
Xiao, Danni;
Yang, Jing

Publication type:

Article

Oral aripiprazole in the treatment of tic disorders in China: a cost-effectiveness analysis based on a mapping algorithm derived from a Chinese children and adolescents population.

Published in:

Child & Adolescent Psychiatry & Mental Health, 2024, v. 18, n. 1, p. 1, doi. 10.1186/s13034-024-00786-0

By:

Chen, Chaoxin;
Chen, Tingting;
Ke, Zhongling;
Wu, Yi;
Liu, Maobai;
Chen, Yanhui;
Zheng, Bin

Publication type:

Article

External Evaluation of Population Pharmacokinetic Models for High‐Dose Methotrexate in Adult Patients with Hematological Tumors.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 4, p. 437, doi. 10.1002/jcph.2392

By:

Chen, Shengyang;
Huang, Lifeng;
Huang, Weikun;
Zheng, You;
Shen, Li;
Liu, Maobai;
Chen, Wansheng;
Wu, Xuemei

Publication type:

Article

Limited Sampling Strategies for Estimating Busulfan Area Under the Concentration–Time Curve: Based on Peak and Trough Concentrations in Saliva.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 58, doi. 10.1002/jcph.2345

By:

Xu, Baohua;
Zhou, Jianxing;
Zheng, You;
Xu, Ruichao;
Liu, Qingxia;
Li, Dandan;
Liu, Maobai;
Wu, Xuemei

Publication type:

Article

Population Pharmacokinetic Modeling Using Polymyxin B Free Plasma Concentrations From Published Reports and Evaluation of Dosage Regimens Based on Monte Carlo Simulation in Critically Ill Patients.

Published in:

Journal of Clinical Pharmacology, 2023, v. 63, n. 9, p. 1036, doi. 10.1002/jcph.2261

By:

Zheng, You;
Xu, Baohua;
Chen, Shengyang;
Liu, Maobai;
Huang, Huiping;
Wang, Jingting;
Wu, Xuemei

Publication type:

Article

Can Published Population Pharmacokinetic Models of Busulfan Be Used for Individualized Dosing in Chinese Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation? An External Evaluation.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 5, p. 609, doi. 10.1002/jcph.1992

By:

Huang, Huiping;
Liu, Maobai;
Ren, Jinhua;
Hu, Jianda;
Lin, Shenglu;
Li, Dandan;
Huang, Weikun;
Chen, Shaozhen;
Yang, Ting;
Wu, Xuemei

Publication type:

Article

Three methods to optimise polymyxin B dosing using estimated AUC after first dose: validation with the data generated by Monte Carlo simulation.

Published in:

Xenobiotica, 2024, v. 54, n. 9, p. 615, doi. 10.1080/00498254.2024.2370051

By:

Liu, Qingxia;
Zhou, Jianxing;
Zheng, You;
Xu, Baohua;
Li, Dandan;
Liu, Maobai;
Zhang, Xiaohan;
Wu, Xuemei

Publication type:

Article

Saliva as a noninvasive sampling matrix for therapeutic drug monitoring of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation: A prospective population pharmacokinetic and simulation study.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 9, p. 1238, doi. 10.1002/psp4.13004

By:

Xu, Baohua;
Yang, Ting;
Zhou, Jianxing;
Zheng, You;
Wang, Jingting;
Liu, Qingxia;
Li, Dandan;
Zhang, Yifan;
Liu, Maobai;
Wu, Xuemei

Publication type:

Article

Systematic review and meta-analysis: de novo combination of nucleos(t)ide analogs and pegylated interferon alpha versus pegylated interferon alpha monotherapy for the functional cure of chronic hepatitis B.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1403805

By:

Na Wei;
Bin Zheng;
Hongfu Cai;
Na Li;
Jing Yang;
Maobai Liu

Publication type:

Article

Comparison of immune checkpoint inhibitors related to pulmonary adverse events: a retrospective analysis of clinical studies and network meta-analysis.

Published in:

BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03285-3

By:

Hong, Baohui;
Du, Bin;
Chen, Rong;
Zheng, Caiyun;
Ni, Ruping;
Liu, Maobai;
Yang, Jing

Publication type:

Article

Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database.

Published in:

BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03274-6

By:

Zhou, Jianxing;
Zheng, You;
Xu, Baohua;
Long, Songjun;
Zhu, Li-e;
Liu, Yunhui;
Li, Chengliang;
Zhang, Yifan;
Liu, Maobai;
Wu, Xuemei

Publication type:

Article

Cost-effectiveness analysis of anlotinib plus chemotherapy with or without benmelstobart versus chemotherapy alone for extensive-stage small-cell lung cancer in China.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1484650

By:

You, Caicong;
Zhang, Jiahao;
Lei, Jianying;
Fu, Wu;
Zheng, Bin;
Liu, Maobai;
Li, Na

Publication type:

Article

Cost‐effectiveness analysis of screening for primary aldosteronism in China.

Published in:

Clinical Endocrinology, 2021, v. 95, n. 3, p. 414, doi. 10.1111/cen.14478

By:

Li, Na;
Huang, Jingze;
Zheng, Bin;
Cai, Hongfu;
Liu, Maobai;
Liu, Libin

Publication type:

Article

Clopidogrel Versus Aspirin in Patients with Recent Ischemic Stroke and Established Peripheral Artery Disease: An Economic Evaluation in a Chinese Setting.

Published in:

Clinical Drug Investigation, 2015, v. 35, n. 6, p. 365, doi. 10.1007/s40261-015-0290-x

By:

Li, Te;
Liu, Maobai;
Ben, He;
Xu, Zhenxing;
Zhong, Han;
Wu, Bin

Publication type:

Article

Managing delayed or missed pregabalin doses in patients with focal epilepsy: a Monte Carlo simulation study.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 1, p. 150, doi. 10.1007/s11096-023-01657-y

By:

Xie, Helin;
Zheng, You;
Wang, Chenyu;
Song, Shiwei;
Dai, Yihai;
Huang, Xian;
Liu, Maobai;
Wu, Xuemei

Publication type:

Article

Association of NR1I2 Polymorphism with Midazolam Clearance in Mechanically Ventilated ICU Patients: A Population Pharmacokinetic and Pharmacogenetic Study.

Published in:

Drug Design, Development & Therapy, 2025, v. 19, p. 1527, doi. 10.2147/DDDT.S495647

By:

Xie, Helin;
Zheng, You;
Zhang, Hui;
Guo, Yanmei;
Liu, Maobai;
Weng, Qinyong;
Wu, Xuemei

Publication type:

Article

A systematic evaluation of population pharmacokinetic models for polymyxin B in patients with liver and/or kidney dysfunction.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2024, v. 51, n. 6, p. 685, doi. 10.1007/s10928-024-09916-9

By:

Li, Xueyong;
Cheng, Yu;
Zhang, Bingqing;
Chen, Bo;
Chen, Yiying;
Huang, Yingbing;
Lin, Hailing;
Zhou, Lili;
Zhang, Hui;
Liu, Maobai;
Que, Wancai;
Qiu, Hongqiang

Publication type:

Article

Evaluation of Clinical Practice Guidelines for the Use of Supplementary Parenteral Nutrition in ICU Patients.

Published in:

International Journal of General Medicine, 2024, v. 17, p. 3933, doi. 10.2147/IJGM.S469991

By:

Xiao, Deying;
Xie, Long;
Lin, Wenhong;
Fu, Jinhua;
Deng, Lin;
Zhuang, Qian;
Liu, Maobai

Publication type:

Article

Population Pharmacokinetics-Based Evaluation of Ceftazidime-Avibactam Dosing Regimens in Critically and Non-Critically Ill Patients With Carbapenem-Resistant Klebsiella pneumoniae.

Published in:

Infection & Drug Resistance, 2025, v. 18, p. 941, doi. 10.2147/IDR.S495279

By:

Chen, Yiying;
Chen, Bo;
Huang, Yingbin;
Li, Xueyong;
Wu, Junnan;
Lin, Rongqi;
Chen, Ming;
Liu, Maobai;
Qiu, Hongqiang;
Cheng, Yu

Publication type:

Article

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma: a cost-effectiveness analysis.

Published in:

Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231171038

By:

Cao, Xueqiong;
Zhang, Mingming;
Li, Na;
Zheng, Bin;
Liu, Maobai;
Song, Xiaobing;
Cai, Hongfu

Publication type:

Article

Efficacy and safety of adding bevacizumab biosimilar or original drug to platinum-based chemotherapy as first-line treatment in patients with advanced NSCLC: a systematic review and meta-analysis.

Published in:

Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221130501

By:

Yang, Liu;
Liu, Maobai;
Cao, Xueqiong;
Li, Na;
Zheng, Bin;
Deng, Jianhao;
Cai, Hongfu

Publication type:

Article

First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone for advanced esophageal cancer: a cost-effectiveness analysis.

Published in:

Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221122733

By:

Cao, Xueqiong;
Cai, Hongfu;
Li, Na;
Zheng, Bin;
Zheng, Zhiwei;
Liu, Maobai

Publication type:

Article

Cost-effectiveness analysis of nivolumab plus ipilimumab versus chemotherapy as the first-line treatment for unresectable malignant pleural mesothelioma.

Published in:

Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221116604

By:

Yang, Liu;
Cao, Xueqiong;
Li, Na;
Zheng, Bin;
Liu, Maobai;
Cai, Hongfu

Publication type:

Article

Systematic review and cost-effectiveness of pharmacokinetically guided sunitinib individualized treatment for patients with metastatic renal cell carcinoma.

Published in:

Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221085212

By:

Chen, Tingting;
Chen, Jiahe;
Chen, Chaoxin;
Guo, Jianming;
He, Xin;
Zheng, Song;
Liu, Maobai;
Zheng, Bin

Publication type:

Article

Metabolomic profiling reveals the mechanisms underlying the nephrotoxicity of methotrexate in children with acute lymphoblastic leukemia.

Published in:

Pediatric Blood & Cancer, 2023, v. 70, n. 10, p. 1, doi. 10.1002/pbc.30578

By:

Cheng, Yu;
Chen, Yanan;
Zhao, Mingming;
Wang, Minglu;
Liu, Maobai;
Zhao, Limei

Publication type:

Article

Optimization of oral isavuconazole dose for population in special physiological or pathological state: a physiologically based pharmacokinetics model-informed precision dosing.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 9, p. 2379, doi. 10.1093/jac/dkae240

By:

Zhou, Jianxing;
Xu, Baohua;
Zheng, You;
Huang, Huiping;
Wei, Zipeng;
Chen, Shengyang;
Huang, Wei;
Liu, Maobai;
Zhang, Yifan;
Wu, Xuemei

Publication type:

Article

External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.835037

By:

Huiping Huang;
Qingxia Liu;
Xiaohan Zhang;
Helin Xie;
Maobai Liu;
Nupur Chaphekar;
Xuemei Wu

Publication type:

Article

First-line treatment with zolbetuximab plus CAPOX for ClDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a cost-effectiveness analysis.

Published in:

Therapeutic Advances in Gastroenterology, 2024, p. 1, doi. 10.1177/17562848241297052

By:

Lei, Jianying;
Zhang, Jiahao;
You, Caicong;
Fu, Wu;
Liu, Maobai;
Li, Na

Publication type:

Article

Multiple Adverse Reactions Associated With the Use of Second-Generation Antipsychotics in People With Alzheimer's Disease: A Pharmacovigilance Analysis Based on the FDA Adverse Event Reporting System.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 3, p. 213, doi. 10.1177/10600280241271093

By:

Zhou, Jianxing;
Wei, Zipeng;
Huang, Wei;
Liu, Maobai;
Wu, Xuemei

Publication type:

Article

Exploring the Link Between Exogenous Thyroid Hormones and Dementia Symptoms: A Real-World Disproportionality Analysis of FDA Adverse Event Reporting System.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 1, p. 23, doi. 10.1177/10600280241252211

By:

Zhou, Jianxing;
Lai, Weipeng;
Wei, Zipeng;
Xu, Baohua;
Liu, Maobai;
Zhang, Nanwen;
Wu, Xuemei

Publication type:

Article

Fixed-dose administration and pharmacokinetically guided adjustment of busulfan dose for patients undergoing hematopoietic stem cell transplantation: a meta-analysis and cost-effectiveness analysis.

Published in:

Annals of Hematology, 2022, v. 101, n. 3, p. 667, doi. 10.1007/s00277-021-04733-3

By:

Chen, Tingting;
Chen, Chaoxin;
He, Xin;
Guo, Jianming;
Liu, Maobai;
Zheng, Bin

Publication type:

Article

Gelsemium elegans Benth: Chemical Components, Pharmacological Effects, and Toxicity Mechanisms.

Published in:

Molecules, 2021, v. 26, n. 23, p. 7145, doi. 10.3390/molecules26237145

By:

Lin, Hailing;
Qiu, Hongqiang;
Cheng, Yu;
Liu, Maobai;
Chen, Maohua;
Que, Youxiong;
Que, Wancai

Publication type:

Article

Development and validation of a nomogram for predicting immune‐related pneumonitis after sintilimab treatment.

Published in:

Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6708

By:

Hong, Baohui;
Chen, Rong;
Zheng, Caiyun;
Liu, Maobai;
Yang, Jing

Publication type:

Article

Molecular Mechanism of Gelsemium elegans (Gardner and Champ.) Benth. Against Neuropathic Pain Based on Network Pharmacology and Experimental Evidence.

Published in:

Frontiers in Pharmacology, 2022, v. 12, p. 1, doi. 10.3389/fphar.2021.792932

By:

Que, Wancai;
Wu, Zhaoyang;
Chen, Maohua;
Zhang, Binqing;
You, Chuihuai;
Lin, Hailing;
Zhao, Zhichang;
Liu, Maobai;
Qiu, Hongqiang;
Cheng, Yu

Publication type:

Article

Cost-Effectiveness Analysis of Camrelizumab Versus Chemotherapy as Second-Line Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma.

Published in:

Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.732912

By:

Cai, Hongfu;
Xu, Baohua;
Li, Na;
Zheng, Bin;
Zheng, Zhiwei;
Liu, Maobai

Publication type:

Article

Cost-Effectiveness Analysis of Olaparib Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.632818

By:

Li, Na;
Zheng, Huanrui;
Huang, Yanlei;
Zheng, Bin;
Cai, Hongfu;
Liu, Maobai

Publication type:

Article

Cost-effectiveness analysis of axicabtagene ciloleucel as a second-line treatment for diffuse large B-cell lymphoma in China and the United States.

Published in:

Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231168215

By:

Li, Na;
Lei, Jianying;
Zhang, Jiahao;
Cai, Hongfu;
Zheng, Bin;
Yang, Ting;
Liu, Maobai;
Hu, Jianda

Publication type:

Article

Cost-Effectiveness Analysis of Dacomitinib versus Gefitinib in the First-Line Treatment of EGFR-Positive Advanced or Metastatic Non-Small Cell Lung Cancer.

Published in:

Cancer Management & Research, 2021, v. 13, p. 4263, doi. 10.2147/CMAR.S293983

By:

Zhang, Longfeng;
Li, Na;
Liu, Maobai;
Zheng, Bin;
Wu, Zhijuan;
Cai, Hongfu

Publication type:

Article

Economic Evaluations of Immune Checkpoint Inhibitors for Patients with Non-Small Cell Lung Cancer: A Systematic Review.

Published in:

Cancer Management & Research, 2020, v. 12, p. 4503, doi. 10.2147/CMAR.S248020

By:

Li, Na;
Zheng, Huanrui;
Zheng, Bin;
Chen, Chaoxin;
Cai, Hongfu;
Liu, Maobai

Publication type:

Article

Cost-Effectiveness Analysis Of Pembrolizumab In The Treatment Of Advanced Recurrent Metastatic Head And Neck Squamous Cell Carcinoma In China And The United States.

Published in:

Cancer Management & Research, 2019, v. 11, p. 9483, doi. 10.2147/CMAR.S226243

By:

Liu, Maobai;
Han, Sijie;
Zheng, Bin;
Cai, Hongfu;
Yang, Jing;
Zhuang, Qian;
Li, Na

Publication type:

Article

Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer.

Published in:

Cancer Management & Research, 2019, v. 11, p. 9195, doi. 10.2147/CMAR.S223441

By:

Liu, Maobai;
Zhang, Longfeng;
Huang, Qishu;
Li, Na;
Zheng, Bin;
Cai, Hongfu

Publication type:

Article

A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.

Published in:

BMC Complementary Medicine & Therapies, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12906-021-03273-7

By:

Que, Wancai;
Chen, Maohua;
Yang, Ling;
Zhang, Bingqing;
Zhao, Zhichang;
Liu, Maobai;
Cheng, Yu;
Qiu, Hongqiang

Publication type:

Article

The safety profile of usage of glucagon‐like peptide‐1 receptor agonists in pregnancy: A pharmacovigilance analysis based on the Food and Drug Administration Adverse Event Reporting System.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1272, doi. 10.1111/bcp.16354

By:

Zhou, Jianxing;
Wei, Zipeng;
Lai, Weipeng;
Liu, Maobai;
Wu, Xuemei

Publication type:

Article

Population pharmacokinetics of polymyxin B in patients with liver dysfunction.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 12, p. 3561, doi. 10.1111/bcp.15855

By:

Li, Xueyong;
Cheng, Yu;
Chen, Bo;
Chen, Yiying;
Huang, Yingbin;
Zhang, Bingqing;
Que, Wancai;
Liu, Maobai;
Zhang, Hui;
Qiu, Hongqiang

Publication type:

Article

Movement disorders associated with antiseizure medications: A real‐world disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 11, p. 3389, doi. 10.1111/bcp.15836

By:

Zhou, Jianxing;
Wei, Zipeng;
Chen, Shengyang;
Xie, Helin;
Huang, Wei;
Liu, Maobai;
Wu, Xuemei

Publication type:

Article

The association between proton pump inhibitor use and systemic anti‐tumour therapy on survival outcomes in patients with advanced non‐small cell lung cancer: A systematic review and meta‐analysis.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 7, p. 3052, doi. 10.1111/bcp.15276

By:

Wei, Na;
Zheng, Bin;
Que, Wancai;
Zhang, Jin;
Liu, Maobai

Publication type:

Article

Risk of ophthalmic adverse drug reactions in patients prescribed glucagon-like peptide 1 receptor agonists: a pharmacovigilance study based on the FDA adverse event reporting system database.

Published in:

Endocrine (1355008X), 2025, v. 88, n. 1, p. 80, doi. 10.1007/s12020-024-04112-8

By:

Zhou, Jianxing;
Huang, Wei;
Xie, Yunzhen;
Shen, Haobin;
Liu, Maobai;
Wu, Xuemei

Publication type:

Article

From population to individuals: a new indicator for evaluating the appropriateness of clinical application of antibiotics.

Published in:

BMC Pharmacology & Toxicology, 2018, v. 19, n. 1, p. N.PAG, doi. 10.1186/s40360-018-0245-y

By:

Zheng, Bin;
Li, Na;
Hu, Zhijian;
Liu, Maobai

Publication type:

Article